fda safety communication semaglutide naion 2025 GLP-1 Receptor Agonists and vision risk PDF) Is Semaglutide Linked to

It can hit self-esteem hard, and its often the reason someone stops taking a medication thats otherwise helping them

The Treat and Reduce Obesity Act (TROA) that was recently introduced in Congress would allow Medicare to cover GLP-1s and similar drugs for weight loss

The benefits of Semaglutide treatment extend beyond just weight loss and diabetes management

From my perspective, we have a lot higher priorities when I see people in my clinic, Farhadi said.

Type II diabetes associated with obesity

According to NICE guidance on type 2 diabetes management (NG28), healthcare professionals should counsel patients about expected side effects before initiating GLP-1 receptor agonist therapy, emphasising that most gastrointestinal symptoms are transient and manageable with appropriate strategies